WORK Medical Technology (WOK) Equity Ratio (2023 - 2025)

WORK Medical Technology (WOK) posted Equity Ratio of 0.64 for Q3 2025, up 40.98% on a QoQ basis from 0.45 in Q1 2025, and up 43.99% year-over-year from 0.44 in Q3 2024.

WORK Medical Technology (WOK) has 3 years of Equity Ratio data on file, last reported at 0.64 in Q3 2025.

  • In Q3 2025, Equity Ratio rose 43.99% year-over-year to 0.64; the TTM figure through Sep 2025 stood at 0.64 (up 43.99% YoY), while the FY2025 annual figure was 0.64, up 43.99% from the prior year.
  • Equity Ratio climbed to 0.64 in Q3 2025, from 0.45 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.64 in Q3 2025 and bottomed at 0.37 in Q3 2023.
  • A 3-year average of 0.48 and a median of 0.45 in 2024 frame the typical range for Equity Ratio.
  • Annual changes were most pronounced in 2024 — Equity Ratio increased 20.89% — and 2025, when it jumped 43.99%.
  • Year by year, Equity Ratio stood at 0.37 in 2023, then grew by 20.89% to 0.44 in 2024, then soared by 43.99% to 0.64 in 2025.
  • The last three Equity Ratio figures came in at 0.64 (Q3 2025), 0.45 (Q1 2025), and 0.44 (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.47
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.50
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.54
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.59
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.78
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.45
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.29
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.67
10 WORK Medical Technology - - - 0.64

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 0.64
Mar 31, 2025 0.45
Sep 30, 2024 0.44
Sep 30, 2023 0.37